X-ACTXML Active Content Technologies Council
References in periodicals archive ?
An updated study of the landmark X-ACT trial, tracking data at 4.
The X-ACT feature provides an easy, convenient way to calibrate the Accel-a-Writer 3G to unequaled accuracy.
According to Heimann, recent generations of the company's X-ray security equipment can easily be retro-fitted with the X-ACT sub-systems and components.
Cardius X-ACT is a rapid cardiac SPECT/VCT imaging system that features a low-dose volume-computed tomography (VCT) attenuation correction system that significantly reduces artifacts in the images caused by overlying tissues increasing interpretive ease and accuracy.
In August this year, Roche filed an additional indication in Europe and the US for Xeloda to treat colon cancer patients after surgery, based on the successful results of the X-ACT trial.
We're really thrilled to have the ability to reprogram the SALAGAR X-ACT and use identical hardware in such diverse products, and do it all in a world-beating development timescale", he added.
We incorporated SALAGAR X-ACT technology into the Symphony S210 to compensate for the natural spikes that arise from mid-bass cone resonances and other effects coming from transducer-cabinet integration," said Gary DiChiara, SALAGAR vice president and co-founder.
25 /PRNewswire/ -- Five-year follow-up overall survival data from the X-ACT (Xeloda in Adjuvant Colon Cancer Trial) study show that oral chemotherapy Xeloda(R) (capecitabine) is as effective as the current standard treatment - intravenous bolus 5-FU/LV (5-fluorouracil/ leucovorin) - in the adjuvant treatment of Dukes' C colon cancer.
X-ACT (Advanced Contents Tracking) - An automated recognition software program which identifies suspicious material screened in HI-SCAN series systems can be incorporated into the MSC 40.
Professor Jim Cassidy, Cancer Research UK Professor of Oncology and Chair of Medical Oncology, Beatson Oncology Centre, and University of Glasgow in Glasgow, Scotland, another of the lead investigators of the X-ACT trial agreed, commenting, "According to some recent studies, most patients with cancer would prefer a convenient oral chemotherapy if they did not have to sacrifice efficacy.
He has published over 140 peer-reviewed articles in scientific and medical journals and has led high profile oncology clinical studies, including most recently, the X-ACT study which contributed to the U.